Overview of Congressman Taylor’s Stock Transactions
Republican Congressman David J. Taylor of Ohio filed disclosures on September 5, 2026, detailing six stock trades involving sectors such as biotechnology, technology, semiconductors, utilities, and regional banking. The transaction values ranged between $1,001 and $15,000. Market analysts reviewed the disclosures on September 7 to assess potential portfolio and policy implications.
Taylor acquired shares of American Electric Power Company (NASDAQ: AEP) and Broadcom Inc. (NASDAQ: AVGO) in his personal retirement account (IRA) and trust account. Additionally, he purchased shares of Fifth Third Bancorp (NASDAQ: FITB) within his trust account. Offsetting these buys, he sold holdings in Amgen Inc. (NASDAQ: AMGN) from both accounts, and divested shares of Microsoft Corporation (NASDAQ: MSFT) and Vertex Pharmaceuticals (NASDAQ: VRTX) from his trust account.
Committee Roles Informing Investment Focus
Taylor serves on the House Agriculture Committee and the Transportation and Infrastructure Committee, actively participating in five subcommittees covering agricultural commodities, risk management, water resources, transportation, and pipeline infrastructure. His involvement in agricultural lending and crop insurance policy connects directly to regional banks’ business environments, including institutions like Fifth Third Bancorp.
Stock Performance Update
In 2026 to date, American Electric Power's stock has risen 7.5%, trading near $124.50 with a market capitalization around $67.8 billion. Broadcom’s share price advanced approximately 2.96% to about $357.90, reflecting a market cap of $1.7 trillion.
Conversely, Fifth Third Bancorp’s shares declined by 11.92%, trading near $21.80 and valued at approximately $38.2 billion. Amgen experienced strong gains with a 33.45% increase, trading at $437.23 and holding a market cap around $236.4 billion.
Microsoft’s stock appreciated 5.66%, reaching $499.70 and nearing a $3.7 trillion valuation. Vertex Pharmaceuticals posted a 20.79% increase, trading near $546.12 with a market value of about $138.4 billion.
Analysis of Portfolio Adjustments
Taylor’s recent transactions indicate a strategic reduction in biotechnology and software sector exposure, in favor of increased holdings in semiconductors, utilities, and regional banking stocks. This shift likely reflects a portfolio recalibration aligned with his committee responsibilities and broader policy focus.
Although the disclosures provide clear details on individual stock trades, ongoing scrutiny by market participants and regulators continues regarding congressional members’ trading activities, particularly concerning access to non-public information and related conflict of interest risks. Enhanced transparency and regulatory oversight remain key considerations going forward.